Literature DB >> 315113

Non-HLA lymphocyte cytotoxins in various diseases.

G Ozturk, P I Terasaki.   

Abstract

Cold non-HLA lymphocyte cytotoxins were found to be principally reactive against B lymphocytes. These antibodies were studied in 1335 patients with a wide range of diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), scleroderma, Hashimoto's disease, asthma, diabetes, lymphoma, psoriasis, leukemia, multiple sclerosis, and also in healthy donors. Antibodies reactive to B lymphocytes in the cold or warm test conditions were not directed against HLA specificities. Since B lymphocytes differ from T lymphocytes principally in that they have surface immunoglobulin, it is postulated that at least one target antigen of cold lymphocyte cytotoxins is not a virus, infectious agent, or a genetically determined structural antigen, but, rather, simply immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315113     DOI: 10.1111/j.1399-0039.1979.tb00821.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

Review 1.  Cardiac transplantation. Selection, immunosuppression, and survival.

Authors:  L W Stevenson; H Laks; P I Terasaki; B D Kahan; D C Drinkwater
Journal:  West J Med       Date:  1988-11

Review 2.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

3.  A study of lymphocytotoxins in families of patients with systemic lupus erythematosus.

Authors:  R A Hazelton
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

4.  Autoantibody against TL.6. Presence in a widely-distributed anti-Ia serum.

Authors:  P F Halloran; S K Stylianos
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena.

Authors:  K C Herold; A Huen; L Gould; H Traisman; A H Rubenstein
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

6.  Lymphocytotoxic antibodies in primary biliary cirrhosis.

Authors:  A Parés; J Martorell; J Caballería; J Vives; M Bruguera; J Rodés
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

7.  Antibody-mediated cellular cytotoxicity against Raji cells ADCC(Raji): evaluation of false positives in the detection of circulating immune complexes by Raji-cell assay.

Authors:  M K Dasgupta; T Kovithavongs; J Schlaut; B M Longenecker; J B Dossetor
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

8.  Cell surface antibodies in type 1 (insulin-dependent) diabetic patients. II. Presence of immunoglobulins M which bind to lymphocytes.

Authors:  O Segers; F Gorus; G Somers; M Van de Winkel; M Vercammen; D Pipeleers
Journal:  Diabetologia       Date:  1989-08       Impact factor: 10.122

9.  Occurrence of lymphocytotoxins in multi-case rheumatoid arthritis families: relation to HLA.

Authors:  V Taneja; N K Mehra; R R Singh; C Anand; A N Malaviya
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

10.  Characterization of cold reactive lymphocytotoxic antibodies in malaria.

Authors:  M J Gilbreath; K Pavanand; R P MacDermott; R A Wells; M A Ussery
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.